Congenital Heart Surgery in Pediatric Patients With Beta-Thalassemia Major

NCT04367701 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 41

Last updated 2020-04-29

No results posted yet for this study

Summary

Authors compared incidence of Hemolysis on Cardiopulmonary Bypass surgery for repair of congenital heart disease in Pediatric Patients between patients with thalassemia major and control group

Conditions

  • Hemolysis

Interventions

DIAGNOSTIC_TEST

Hemolysis

Authors measured free plasma hemoglobin concentration in gram

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • Galal Mo El kadi, Doctor · Professor

Eligibility

Min Age
6 Months
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-15
Primary Completion
2019-08-15
Completion
2019-08-30
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04367701 on ClinicalTrials.gov